Henry W Pratt, P.A. Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 3605 Hospital Rd, Suite M, Atwater, CA 95301 Phone: 209-383-5500 Fax: 209-383-6910 |
Jonathan Leong, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1775 3rd St, Atwater, CA 95301 Phone: 209-358-5611 |
Muhammad Iqbal Choudhry, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1775 Third Street, Atwater, CA 95301 Phone: 209-358-5611 Fax: 209-358-0219 |
Lorena Magana Magana, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 3605 Hospital Rd, Atwater, CA 95301 Phone: 209-381-2000 Fax: 209-384-2341 |
Christine Emma Mae Viney, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1675 Shaffer Rd, Atwater, CA 95301 Phone: 209-383-5500 |
Maricela Estrada, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1251 Grove Ave, Atwater, CA 95301 Phone: 209-358-8425 Fax: 209-358-0123 |
Thomas Patrick Dowell, PAC Physician Assistant Medicare: Medicare Enrolled Practice Location: 3605 Hospital Rd, Atwater, CA 95301 Phone: 209-381-2000 Fax: 209-726-0278 |
News Archive
CytRx Corporation, a biopharmaceutical company specializing in oncology, today reported financial results for the three months and nine months ended September 30, 2010, and provided a business update. The Company also announced the filing of a shelf registration statement with the Securities and Exchange Commission to replace its existing shelf registration, which expires in December 2010.
A beautiful, but often deadly, snail from the sea has been revealed as a largely untapped source of natural healing powers for a range of illnesses from chronic pain to diseases of the brain.
Phenex Pharmaceuticals AG, a drug discovery and development company headquartered in Ludwigshafen, Germany, today announced the closure of its Series C financing round with a volume of 6 M € (7,8 M USD) bringing the total amount of funds raised to 17,2 M € (22,4 M USD).
Boston Scientific Corporation today announced comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS Liberte Paclitaxel-Eluting Stent System in a variety of lesions and patient groups.
› Verified 6 days ago